title: [Farmacological effects of anti-S 100 in release-active form and mechanisms of their realization].
abstract: Antibodies to 5100 proteins (anti-5100) in release-active form (RA anti-5100) are an active component of some domestic drugs(tenoten, tenoten for children, divaza, brizantin, kolofort and proproten-100). The authors present the results of preclinical and clinical trials (with detailed consideration of experimental data) which demonstrated a wide spectrum of specific pharmacological activity and safety as well as mechanisms of anti-5100 action.
authors.affiliation: 'Materia Medica Holding', Moscow.
authors.forename: G R
authors.initials: GR
authors.lastname: Khakimova
authors.affiliation: Zakusov Research Institute of Pharmacology, Moscow.
authors.forename: T A
authors.initials: TA
authors.lastname: Voronina
authors.affiliation: 'Materia Medica Holding', Moscow.
authors.forename: Yu L
authors.initials: YL
authors.lastname: Dugina
authors.affiliation: 'Materia Medica Holding', Moscow.
authors.forename: I A
authors.initials: IA
authors.lastname: Ertuzun
authors.affiliation: 'Materia Medica Holding', Moscow; Research Institute of General pathology and pathophysiology, Moscow.
authors.forename: O I
authors.initials: OI
authors.lastname: Epshtein
mesh_terms: D000906:Antibodies / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D000068456:Clinical Studies as Topic; D004353:Drug Evaluation, Preclinical; D006801:Humans; D009418:S100 Proteins / Q000037:antagonists & inhibitors* / Q000276:immunology*; D013315:Stress, Psychological / Q000276:immunology / Q000628:therapy*
chemical_list: D000906:Antibodies; D009418:S100 Proteins